Drugs / 131I-aGPC3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07353333 | Jan → Aug 2026 overdue | hepatocellular carcinoma | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 131I-aGPC3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07353333 ↗ |
| Modality | Diagnostic / imaging agent | “targeted GPC3-specific imaging agents” NCT07353333 ↗ |
| Target | GPC3 | “targeting GPC3” NCT07353333 ↗ |